EDX Medical Group Plc
(“EDX Medical” or the “Company”)
Total Voting Rights - Correction
In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, the Company hereby announces that it has 252,500,000 ordinary shares of
The above figure of 252,500,000 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.
The above figure reflects the Ordinary Shares issued in connection with the acquisition of Torax Biosciences Ltd, announced on February 17, 2023, and corrects the Total Voting Rights figure set out in that announcement.
The directors of the Company accept responsibility for the contents of this announcement.
For more information, please contact:
EDX Medical PLC
Tel: 020 7220 9795
Media House International,
Tel: +44 (0) 7788 414856: